We remain committed to rigorous expense management and capital allocation. This can be seen by trimming expense guidance while we invest in our mission-critical R&D priorities and keeping our projected free cash flow essentially unchanged.
Aug 5, 2026 / receipt
We remain committed to rigorous expense management and capital allocation. This can be seen by trimming expense guidance while we invest in our mission-critical R&D priorities and keeping our projected free cash flow essentially unchanged.
Aug 5, 2026 / receipt, needs a key / Mike Morrissey, CEO | earnings call 2026-08-05 | transcript f3616be7-ee92-4bb7-bf60-8cc53119ce2c | chars 5935-6174 | segment 5
And, you know, we think with the revenue growth we're generating and with the continued prudent expense management, including R&D expense in the billion-dollar range, we think that we'll be able to fund all three of those elements, and we'll continue to invest in R&D and invest in BD and invest in share repurchase.
Nov 4, 2025 / receipt, needs a key / Chris, CFO | earnings call 2025-11-04 | transcript 3a4e908a-d1e8-44e6-a72e-78e68af3c9a0 | chars 52870-53186 | segment 52
Senior Commercial Data Management Manager | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Senior-Manger--Commercial-Data-Management_JR6899", "remote": false, "categor
company_statement / Sep 14, 2026 / receipt
Cost Accounting Manager | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Cost-Accounting-Manager_JR7088", "remote": false, "category": "finance_ops", "function": "fina
company_statement / Sep 11, 2026 / receipt
Executive Director, Program Management (Biotechnology Oncology) | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Executive-Director--Program-Management--Biotechnology-
company_statement / Sep 11, 2026 / receipt
Staff Engineer - DevSecOps | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote/Staff-Engineer---DevSecOps_JR7091", "remote": false, "category": "other", "function": "engineering",
company_statement / Sep 11, 2026 / receipt
Associate Clinical Operations Compliance Director (Biotechnology Oncology) | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Associate-Clinical-Operations-Compliance-Di
company_statement / Sep 10, 2026 / receipt
Sr Scientist I - Analytical Development, Biologics CMC | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Sr-Scientist-I---Analytical-Development--Biologics-CMC_JR7055",
company_statement / Sep 10, 2026 / receipt
Associate Clinical Operations Compliance Director (Biotechnology Oncology) | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Associate-Clinical-Operations-Compliance-Di
company_statement / Sep 8, 2026 / receipt
Clinical Operations Compliance Director (Biotechnology Oncology) | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Clinical-Operations-Compliance-Director--Biotechnolog
company_statement / Sep 8, 2026 / receipt
Senior Commercial Drug Substance Manufacturing Manager | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Senior-Commercial-Drug-Substance-Manufacturing-Manager_JR7023",
company_statement / Sep 8, 2026 / receipt
Senior Director, Clinical Operations (Biotech, Oncology) | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Senior-Director--Clinical-Operations--Biotech--Oncology-_JR70
company_statement / Sep 8, 2026 / receipt
Senior Regional Sales Director - Northeast | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-Metro-NY-Home-Office/Senior-Regional-Sales-Director---Northeast_JR7071", "remote": false
company_statement / Sep 3, 2026 / receipt
Senior Market Access Operations Analyst | {"ats": "workday", "city": "Alameda", "state": "CA", "job_id": "/job/Alameda-CA/Senior-Market-Access-Operations-Analyst_JR7053", "remote": false, "category":
company_statement / Sep 2, 2026 / receipt
| Chris Senner | CFO | - | receipt |
| Dana Aftab | EVP of Research and Development | - | receipt |
| Mike Morrissey | CEO | - | receipt |
| PJ Haley | EVP of Commercial | - | receipt |
| 2026-11-03 | earnings call | scheduled | ir |